CVE-2022-47376

CVSS 7.3 HIGHEPSS 0.2%CWE-257

Vexday Risk Score

21Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 7.3EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

13 Jun 2023Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

Affected products

n/a · Alaris Infusion Central

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerability